StereoTactic Ablative RadioTherapy of Cardiac Arrhythmias (START-CA)
Condition(s):Cardiac ArrhythmiaLast Updated:March 13, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Cardiac ArrhythmiaLast Updated:March 13, 2024Recruiting
Condition(s):Radiotherapy; Complications; Ventricular Tachycardia; Structural Heart Abnormality; Heart FailureLast Updated:January 25, 2023Recruiting
Condition(s):NSCLC; NSCLC Stage IV; Oligometastatic Disease; Non Small Cell Lung Cancer; Non Small Cell Lung Cancer Metastatic; EGF-R Positive Non-Small Cell Lung Cancer; NSCLC Stage IV Without EGFR/ALK Mutation; Non-Small Cell Adenocarcinoma; Non-Small Cell Squamous Lung Cancer; Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor; Synchronous Metastases; Metachronous MetastasisLast Updated:January 16, 2024Recruiting
Condition(s):Metastatic TumorsLast Updated:June 15, 2023Recruiting
Condition(s):Stage I Prostate Cancer AJCC v8; Stage II Prostate Cancer AJCC v8; Stage IIA Prostate Cancer AJCC v8; Stage IIB Prostate Cancer AJCC v8; Stage IIC Prostate Cancer AJCC v8Last Updated:November 13, 2023Recruiting
Condition(s):Lung Metastases; Colorectal Cancer MetastaticLast Updated:April 11, 2023Not yet recruiting
Condition(s):Renal TumorLast Updated:May 9, 2023Recruiting
Condition(s):Breast Cancer Stage IV; Oligometastatic DiseaseLast Updated:October 21, 2022Recruiting
Condition(s):Lung CancerLast Updated:August 24, 2023Recruiting
Condition(s):Pancreatic Cancer Non-resectableLast Updated:March 3, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.